Published Date：Jan. 2021
Industry：
Pages：105 Table Number：123
Single User Price：￥3650.00
Enterprise User Price：￥5600.00
Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States. In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter. Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970. Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Neurological Biomarkers market in this environment. In terms of revenue, this research report indicated that the global Neurological Biomarkers market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Neurological Biomarkers industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments. The Bio-Rad Laboratories aims at producing XX Neurological Biomarkers in 2020, with XX % production to take place in global market, QIAGEN accounts for a volume share of XX %. Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Neurological Biomarkers Market by XYZResearch Include China EU USA Japan India Southeast Asia South America Competitive Analysis; Who are the Major Players in Neurological Biomarkers Market? Bio-Rad Laboratories QIAGEN Alseres Pharmaceuticals Abbott Thermo Fisher Scientific Acumen Pharmaceuticals Myriad RBM, Athena Diagnostics AbaStar MDx BANYAN BIOMARKERS ... Major Type of Neurological Biomarkers Covered in XYZResearch report: Metabolomic Genomic Proteomic Imaging Others Application Segments Covered in XYZResearch Market Multiple Sclerosis Alzheimer’s Disease Parkinson’s Disease Autism Spectrum Disorders Others For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents Global Neurological Biomarkers Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate 1 Market Scope 1.1 Product Details and Introduction 1.1.1 Metabolomic -Product Introduction and Major Manufacturers 1.1.2 Genomic -Product Introduction and Major Manufacturers 1.1.3 Proteomic -Product Introduction and Major Manufacturers 1.1.4 Imaging -Product Introduction and Major Manufacturers 1.1.5 Others -Product Introduction and Major Manufacturers 1.2 Market Snapshot 1.2.1 Major Companies Overview 1.2.2 Market Concentration 1.2.3 Six-Year Compound Annual Growth Rate (CAGR) 2 Global Neurological Biomarkers Market Assessment, by Segmentation 2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026) 2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026) 2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026) 3 Regional Market Analysis 3.1 China Neurological Biomarkers Market 3.1.1 Top Companies leading Neurological Biomarkers Development in China (2015-2020) 3.1.2 Sales Value of Major Company in China Market (2015-2020) 3.1.3 China Neurological Biomarkers Price (USD/Unit), by Type (2019-2020) 3.1.4 Sales in China Market, by Type (2015-2026) 3.2 EU Neurological Biomarkers Market 3.2.1 Top Companies leading Neurological Biomarkers Development in EU (2015-2020) 3.2.2 Sales Value of Major Company in EU Market (2015-2020) 3.2.3 EU Neurological Biomarkers Price (USD/Unit), by Type (2019-2020) 3.2.4 Sales in EU Market, by Type (2015-2026) 3.3 USA Neurological Biomarkers Market 3.3.1 Top Companies leading Neurological Biomarkers Development in USA (2015-2020) 3.3.2 Sales Value of Major Company in USA Market (2015-2020) 3.3.3 USA Neurological Biomarkers Price (USD/Unit), by Type (2019-2020) 3.3.4 Sales in USA Market, by Type (2015-2026) 3.4 Japan Neurological Biomarkers Market 3.4.1 Top Companies leading Neurological Biomarkers Development in Japan (2015-2020) 3.4.2 Sales Value of Major Company in Japan Market (2015-2020) 3.4.3 Japan Neurological Biomarkers Price (USD/Unit), by Type (2019-2020) 3.4.4 Sales in Japan Market, by Type (2015-2026) 3.5 India Neurological Biomarkers Market 3.5.1 Top Companies leading Neurological Biomarkers Development in India (2015-2020) 3.5.2 Sales Value of Major Company in India Market (2015-2020) 3.5.3 India Neurological Biomarkers Price (USD/Unit), by Type (2019-2020) 3.5.4 Sales in India Market, by Type (2015-2026) 3.6 Southeast Asia Neurological Biomarkers Market 3.6.1 Top Companies leading Neurological Biomarkers Development in Southeast Asia (2015-2020) 3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020) 3.6.3 Southeast Asia Neurological Biomarkers Price (USD/Unit), by Type (2019-2020) 3.6.4 Sales in Southeast Asia Market, by Type (2015-2026) 3.7 South America Neurological Biomarkers Market 3.7.1 Top Companies leading Neurological Biomarkers Development in South America (2015-2020) 3.7.2 Sales Value of Major Company in South America Market (2015-2020) 3.7.3 South America Neurological Biomarkers Price (USD/Unit), by Type (2019-2020) 3.7.4 Sales in South America Market, by Type (2015-2026) 4 Value Chain (Impact of COVID-19) 4.1 Neurological Biomarkers Value Chain Analysis 4.1.1 Upstream 4.1.2 Downstream 4.2 COVID-19 Impact on Neurological Biomarkers Industry 4.2.1 Industrial Policy Issued Under the Epidemic Situation 4.3 Cost-Under the Epidemic Situation 4.3.1 Cost of Raw Material 4.4 Channel Analysis 4.4.1 Distribution Channel-Under the Epidemic Situation 4.4.2 Distributors 5 Regional Market Forecast (2021-2026) 5.1 Global Neurological Biomarkers Sales and Growth Rate (2021-2026) 5.2 Global Neurological Biomarkers Sales Value and Growth Rate (2021-2026) 6 Neurological Biomarkers Competitive Analysis 6.1 Bio-Rad Laboratories 6.1.1 Bio-Rad Laboratories Company Profiles 6.1.2 Bio-Rad Laboratories Product Introduction 6.1.3 Bio-Rad Laboratories Neurological Biomarkers Production, Revenue (2015-2020) 6.1.4 SWOT Analysis 6.2 QIAGEN 6.2.1 QIAGEN Company Profiles 6.2.2 QIAGEN Product Introduction 6.2.3 QIAGEN Neurological Biomarkers Production, Revenue (2015-2020) 6.2.4 SWOT Analysis 6.3 Alseres Pharmaceuticals 6.3.1 Alseres Pharmaceuticals Company Profiles 6.3.2 Alseres Pharmaceuticals Product Introduction 6.3.3 Alseres Pharmaceuticals Neurological Biomarkers Production, Revenue (2015-2020) 6.3.4 SWOT Analysis 6.4 Abbott 6.4.1 Abbott Company Profiles 6.4.2 Abbott Product Introduction 6.4.3 Abbott Neurological Biomarkers Production, Revenue (2015-2020) 6.4.4 SWOT Analysis 6.5 Thermo Fisher Scientific 6.5.1 Thermo Fisher Scientific Company Profiles 6.5.2 Thermo Fisher Scientific Product Introduction 6.5.3 Thermo Fisher Scientific Neurological Biomarkers Production, Revenue (2015-2020) 6.5.4 SWOT Analysis 6.6 Acumen Pharmaceuticals 6.6.1 Acumen Pharmaceuticals Company Profiles 6.6.2 Acumen Pharmaceuticals Product Introduction 6.6.3 Acumen Pharmaceuticals Neurological Biomarkers Production, Revenue (2015-2020) 6.6.4 SWOT Analysis 6.7 Myriad RBM, Athena Diagnostics 6.7.1 Myriad RBM, Athena Diagnostics Company Profiles 6.7.2 Myriad RBM, Athena Diagnostics Product Introduction 6.7.3 Myriad RBM, Athena Diagnostics Neurological Biomarkers Production, Revenue (2015-2020) 6.7.4 SWOT Analysis 6.8 AbaStar MDx 6.8.1 AbaStar MDx Company Profiles 6.8.2 AbaStar MDx Product Introduction 6.8.3 AbaStar MDx Neurological Biomarkers Production, Revenue (2015-2020) 6.8.4 SWOT Analysis 6.9 BANYAN BIOMARKERS 6.9.1 BANYAN BIOMARKERS Company Profiles 6.9.2 BANYAN BIOMARKERS Product Introduction 6.9.3 BANYAN BIOMARKERS Neurological Biomarkers Production, Revenue (2015-2020) 6.9.4 SWOT Analysis 7 Conclusion
List of Tables and Figures Figure Product Introduction Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020) Figure Global Neurological Biomarkers Production Market Share of Top 5 Players Table CAGR of Major Market (2021-2026) Table CAGR in Terms of Production of Each Type (2015-2026) Table CAGR in Terms of Production of Each Application (2015-2026) Table Global Neurological Biomarkers Sales (K Unit) by Type (2015-2026) Figure Global Neurological Biomarkers Sales (K Unit) and Growth Rate (2015-2026) Figure Global Neurological Biomarkers Sales Market Share (%) by Type (2019 -2020) Table Global Neurological Biomarkers Sales Value (Million USD) by Type (2015-2026) Figure Global Neurological Biomarkers Sales Value (Million USD) and Growth Rate (2015-2026) Figure Global Neurological Biomarkers Sales Value Market Share (%) by Type (2019-2020) Table Global Neurological Biomarkers Sales (K Unit) by Application (2015-2026) Table China Neurological Biomarkers Sales (K Unit) of Major Company (2015-2020) Table China Neurological Biomarkers Sales Market Share of Major Company (2015-2020) Table China Neurological Biomarkers Sales Value (Million USD) of Major Company (2015-2020) Figure China Neurological Biomarkers Sales Value (Million USD) and Growth Rate (2015-2020) Table China Neurological Biomarkers Sales Value Share of Major Company (2015-2020) Table China Neurological Biomarkers Price (USD/Unit), by Type (2019-2020) Table China Neurological Biomarkers Sales (Unit) by Type (2015-2026) Figure China Neurological Biomarkers Sales (Unit) by Type (2015-2026) Table EU Neurological Biomarkers Sales (K Unit) of Major Company (2015-2020) Table EU Neurological Biomarkers Sales Market Share of Major Company (2015-2020) Table EU Neurological Biomarkers Sales Value (Million USD) of Major Company (2015-2020) Figure EU Neurological Biomarkers Sales Value (Million USD) and Growth Rate (2015-2020) Table EU Neurological Biomarkers Sales Value Share of Major Company (2015-2020) Table EU Neurological Biomarkers Price (USD/Unit), by Type (2019-2020) Table EU Neurological Biomarkers Sales (Unit) by Type (2015-2026) Figure EU Neurological Biomarkers Sales (Unit) by Type (2015-2026) Table USA Neurological Biomarkers Sales (K Unit) of Major Company (2015-2020) Table USA Neurological Biomarkers Sales Market Share of Major Company (2015-2020) Table USA Neurological Biomarkers Sales Value (Million USD) of Major Company (2015-2020) Figure USA Neurological Biomarkers Sales Value (Million USD) and Growth Rate (2015-2020) Table USA Neurological Biomarkers Sales Value Share of Major Company (2015-2020) Table USA Neurological Biomarkers Price (USD/Unit), by Type (2019-2020) Table USA Neurological Biomarkers Sales (Unit) by Type (2015-2026) Figure USA Neurological Biomarkers Sales (Unit) by Type (2015-2026) Table Japan Neurological Biomarkers Sales (K Unit) of Major Company (2015-2020) Table Japan Neurological Biomarkers Sales Market Share of Major Company (2015-2020) Table Japan Neurological Biomarkers Sales Value (Million USD) of Major Company (2015-2020) Figure Japan Neurological Biomarkers Sales Value (Million USD) and Growth Rate (2015-2020) Table Japan Neurological Biomarkers Sales Value Share of Major Company (2015-2020) Table Japan Neurological Biomarkers Price (USD/Unit), by Type (2019-2020) Table Japan Neurological Biomarkers Sales (Unit) by Type (2015-2026) Figure Japan Neurological Biomarkers Sales (Unit) by Type (2015-2026) Table India Neurological Biomarkers Sales (K Unit) of Major Company (2015-2020) Table India Neurological Biomarkers Sales Market Share of Major Company (2015-2020) Table India Neurological Biomarkers Sales Value (Million USD) of Major Company (2015-2020) Figure India Neurological Biomarkers Sales Value (Million USD) and Growth Rate (2015-2020) Table India Neurological Biomarkers Sales Value Share of Major Company (2015-2020) Table India Neurological Biomarkers Price (USD/Unit), by Type (2019-2020) Table India Neurological Biomarkers Sales (Unit) by Type (2015-2026) Figure India Neurological Biomarkers Sales (Unit) by Type (2015-2026) Table Southeast Asia Neurological Biomarkers Sales (K Unit) of Major Company (2015-2020) Table Southeast Asia Neurological Biomarkers Sales Market Share of Major Company (2015-2020) Table Southeast Asia Neurological Biomarkers Sales Value (Million USD) of Major Company (2015-2020) Figure Southeast Asia Neurological Biomarkers Sales Value (Million USD) and Growth Rate (2015-2020) Table Southeast Asia Neurological Biomarkers Sales Value Share of Major Company (2015-2020) Table Southeast Asia Neurological Biomarkers Price (USD/Unit), by Type (2019-2020) Table Southeast Asia Neurological Biomarkers Sales (Unit) by Type (2015-2026) Figure Southeast Asia Neurological Biomarkers Sales (Unit) by Type (2015-2026) Table South America Neurological Biomarkers Sales (K Unit) of Major Company (2015-2020) Table South America Neurological Biomarkers Sales Market Share of Major Company (2015-2020) Table South America Neurological Biomarkers Sales Value (Million USD) of Major Company (2015-2020) Figure South America Neurological Biomarkers Sales Value (Million USD) and Growth Rate (2015-2020) Table South America Neurological Biomarkers Sales Value Share of Major Company (2015-2020) Table South America Neurological Biomarkers Price (USD/Unit), by Type (2019-2020) Table South America Neurological Biomarkers Sales (Unit) by Type (2015-2026) Figure South America Neurological Biomarkers Sales (Unit) by Type (2015-2026) Figure Value Chain Structure of Neurological Biomarkers Table Value Chain Table Key Suppliers of Raw Material/Components Table Key Downstream Customer in Each Application Field Table Industry News List of Neurological Biomarkers Figure Cost Structure of Neurological Biomarkers in 2020 Table Distributors/Traders List Table Regional Market Sales (K Unit) (2021-2026) Table Regional Market Sales Share (2021-2026) Figure Global Neurological Biomarkers Sales (Unit), Growth Rate & Market Share (2021-2026) Table Regional Market Sales Value (Million USD) (2021-2026) Table Regional Market Sales Value Share (2021-2026) Figure Global Neurological Biomarkers Sales Value (Million USD), Growth Rate & Market Share (2021-2026) Table Bio-Rad Laboratories Profiles Table Bio-Rad Laboratories Neurological Biomarkers Product Introduction Table Bio-Rad Laboratories Neurological Biomarkers Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Bio-Rad Laboratories SWOT Analysis Table QIAGEN Profiles Table QIAGEN Neurological Biomarkers Product Introduction Table QIAGEN Neurological Biomarkers Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure QIAGEN SWOT Analysis Table Alseres Pharmaceuticals Profiles Table Alseres Pharmaceuticals Neurological Biomarkers Product Introduction Table Alseres Pharmaceuticals Neurological Biomarkers Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Alseres Pharmaceuticals SWOT Analysis Table Abbott Profiles Table Abbott Neurological Biomarkers Product Introduction Table Abbott Neurological Biomarkers Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Abbott SWOT Analysis Table Thermo Fisher Scientific Profiles Table Thermo Fisher Scientific Neurological Biomarkers Product Introduction Table Thermo Fisher Scientific Neurological Biomarkers Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Thermo Fisher Scientific SWOT Analysis Table Acumen Pharmaceuticals Profiles Table Acumen Pharmaceuticals Neurological Biomarkers Product Introduction Table Acumen Pharmaceuticals Neurological Biomarkers Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Acumen Pharmaceuticals SWOT Analysis Table Myriad RBM, Athena Diagnostics Profiles Table Myriad RBM, Athena Diagnostics Neurological Biomarkers Product Introduction Table Myriad RBM, Athena Diagnostics Neurological Biomarkers Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Myriad RBM, Athena Diagnostics SWOT Analysis Table AbaStar MDx Profiles Table AbaStar MDx Neurological Biomarkers Product Introduction Table AbaStar MDx Neurological Biomarkers Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure AbaStar MDx SWOT Analysis Table BANYAN BIOMARKERS Profiles Table BANYAN BIOMARKERS Neurological Biomarkers Product Introduction Table BANYAN BIOMARKERS Neurological Biomarkers Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
